EP3883628A4 - Anwendung von pirfenidon durch inhalation - Google Patents
Anwendung von pirfenidon durch inhalation Download PDFInfo
- Publication number
- EP3883628A4 EP3883628A4 EP19908233.0A EP19908233A EP3883628A4 EP 3883628 A4 EP3883628 A4 EP 3883628A4 EP 19908233 A EP19908233 A EP 19908233A EP 3883628 A4 EP3883628 A4 EP 3883628A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pirfenidone
- application
- via inhalation
- inhalation
- pirfenidone via
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2019/00204A TR201900204A2 (tr) | 2019-01-08 | 2019-01-08 | İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi |
PCT/TR2019/051127 WO2020145924A1 (en) | 2019-01-08 | 2019-12-19 | Application of pirfenidone via inhalation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3883628A1 EP3883628A1 (de) | 2021-09-29 |
EP3883628A4 true EP3883628A4 (de) | 2022-02-09 |
Family
ID=67955558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19908233.0A Pending EP3883628A4 (de) | 2019-01-08 | 2019-12-19 | Anwendung von pirfenidon durch inhalation |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3883628A4 (de) |
TR (1) | TR201900204A2 (de) |
WO (1) | WO2020145924A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3195859A1 (en) * | 2020-10-15 | 2022-04-21 | Epirium Bio Inc. | Inhaled formulations of pgdh inhibitors and methods of use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015106150A1 (en) * | 2014-01-10 | 2015-07-16 | Genoa Pharmaceuticals Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
EP2925395A1 (de) * | 2012-11-28 | 2015-10-07 | E-Nicotine Technology, Inc. | Verfahren und vorrichtungen zur ausgabe einer verbindung |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10034988B2 (en) * | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
EP3524304B1 (de) * | 2014-11-17 | 2023-06-14 | McNeil AB | Elektronisches nikotinabgabesystem |
-
2019
- 2019-01-08 TR TR2019/00204A patent/TR201900204A2/tr unknown
- 2019-12-19 EP EP19908233.0A patent/EP3883628A4/de active Pending
- 2019-12-19 WO PCT/TR2019/051127 patent/WO2020145924A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2925395A1 (de) * | 2012-11-28 | 2015-10-07 | E-Nicotine Technology, Inc. | Verfahren und vorrichtungen zur ausgabe einer verbindung |
WO2015106150A1 (en) * | 2014-01-10 | 2015-07-16 | Genoa Pharmaceuticals Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
EP3883628A1 (de) | 2021-09-29 |
TR201900204A2 (tr) | 2019-02-21 |
WO2020145924A1 (en) | 2020-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3778036A4 (de) | Inhalator | |
EP3636305A4 (de) | Medizinischer vernebler | |
EP4031120A4 (de) | Behandlung von syngap1-enzephalopathie | |
EP3918854A4 (de) | Position von benutzergeräten | |
EP4070183A4 (de) | Verhaltensbasierter vergleich von software | |
EP4069847A4 (de) | Behandlung von erkrankungen der unteren atemwege | |
EP4032513A4 (de) | Mundstück | |
EP3927428A4 (de) | Verfahren zur behandlung von atemwegserkrankungen | |
EP4028085A4 (de) | Intranasale verabreichung von esketamin | |
EP3877382A4 (de) | Neuartige verbindungen zur behandlung von atemwegserkrankungen | |
EP3918931A4 (de) | Geschmacksinhalator | |
EP3619204A4 (de) | Verbindungen zur behandlung von atemwegserkrankungen | |
EP3927328A4 (de) | Inhalierbares therapeutikum | |
EP3883628A4 (de) | Anwendung von pirfenidon durch inhalation | |
EP4055843A4 (de) | Zählung von vorrichtungen | |
EP3884942A4 (de) | Verwendung von bulleyaconitin a | |
EP4037741A4 (de) | Inhalator | |
EP4034130A4 (de) | Pharmazeutische verbindungen und verfahren zur verwendung | |
EP4026548A4 (de) | Verwendung von 5-methyltetrahydrofolat | |
EP4021858A4 (de) | Behandlung von azolen | |
EP3976039A4 (de) | Bisaminochinolin- und bisaminoacridinverbindungen und verfahren zu ihrer verwendung | |
EP3894418A4 (de) | Herstellung von triiodosilanen | |
EP3995017A4 (de) | Geschmacksinhalator | |
EP3991794A4 (de) | Externes präparat für die haut | |
EP3934632A4 (de) | Esketamin zur behandlung von depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210624 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220110 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/4418 20060101ALI20220103BHEP Ipc: A61M 11/04 20060101ALI20220103BHEP Ipc: A61M 15/00 20060101AFI20220103BHEP |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |